This Act may be cited as the "Cure Acceleration Act".
Today's healthcare system is broken because:
-
⏳ Bureaucratic FDA delays block life-saving treatments by 7-12 years
-
🚫 97% of patients are excluded from clinical trials for various reasons, denying access to promising treatments
-
💰 Drug development costs average $2.6B, which is passed on to patients in the form of higher prices
-
📈 80% of R&D focuses on super expensive drugs costing over $100k/year instead of affordable alternatives
-
⏱️ Terminal patients wait 4+ years for breakthrough therapy approvals
-
🌍 US approvals lag 3-5 years behind Europe and Asia
-
🩺 Only 5% of healthcare spending goes to preventive care, despite $1 spent saving $3 in future costs
-
📊 The system ignores real-world evidence about effective treatments
This Act:
- ✅ Guarantees every person's right to try any treatment that passes basic safety testing
- 💻 Creates a free, open platform eliminating billions in trial costs
- 🏆 Rewards companies for developing actual cures and prevention
- 🚪 Removes barriers blocking access to effective treatments
- 📈 Measures and rewards real-world results through comprehensive data collection
- 🤖 Establishes an AI-powered system (FDAi) to continuously analyze treatment outcomes
This Act will:
- 💰 Cut clinical trial costs by over 90% with free open infrastructure
- 💵 Save over $2 trillion annually by incentivizing disease prevention
- ⏩ Reduce time-to-market by years through universal trial participation
- 🎁 Create multi-billion dollar rewards for companies developing actual cures
- 🌐 Enable real price competition through global access and transparent outcomes
A free public decentralized trial platform will:
- 🔄 Replace traditional Phase 1-4 trials with continuous real-world evidence collection
- 📡 Enable efficient safety testing through remote monitoring and rapid signal detection
- 📈 Track safety and effectiveness automatically across the healthcare system
- 🚀 Generate better evidence faster with universal participation
- 🧬 Identify optimal treatments for specific patient profiles swiftly
The platform enables:
- 👥 Broader testing with diverse participants
- 🏠 Any patient to participate from home or remotely
- 📱 Remote participation via telemedicine
- 📲 Patient monitoring through mobile devices and apps
- 📊 Automated outcome tracking via electronic health records
- 📝 Direct patient reporting of experiences and results
- 📚 Continuous real-world evidence collection
The FDAi continuously:
- 🧠 Analyzes all available research and patient data
- 📊 Quantifies positive and negative effects of:
- 💊 Pharmaceutical drugs
- 🍎 Food products and ingredients
- 🥗 Dietary patterns
- 🧪 Treatment combinations
- 🚨 Provides early warnings of potential safety issues
- 🔍 Identifies optimal treatments for specific patient profiles
- 📈 Monitors population-level health outcomes
- 🍽️ Tracks food-drug interactions and dietary impacts
Any patient can:
- 📱 Access the FDA platform showing ranked treatments for their condition
- 🔍 See real-world success rates from other patients with similar conditions
- ✅ Try treatments sequentially from most to least promising
- 🏡 Participate from home through telemedicine and remote monitoring
- 📊 Automatically contribute their results to help rank treatments better
The system:
- 💻 Automates enrollment in decentralized trials
- 🏃 Starts immediately after basic safety verification
- 📈 Updates rankings daily based on patient outcomes
- 🤝 Connects patients directly to treatment providers
- 💊 Ships medications straight to patients' homes
Every patient outcome:
- 📱 Updates treatment rankings automatically
- 🎯 Refines matching of treatments to patient profiles
- 💡 Identifies promising combinations that work better
- ⚡ Speeds up discovery of what works for whom
A decentralized trial platform will:
- 🗃️ Handle all trial data collection
- 📈 Track real-world outcomes
- 🛡️ Monitor safety automatically
- 🔍 Analyze what works best
- 🤝 Connect patients and doctors
- 🌍 Share results globally
- ⚙️ Automate trial recruitment, monitoring, and analysis
The platform eliminates expenses for:
- 💾 Trial software and systems
- 📱 Patient monitoring tools
- 🗄️ Data collection and storage
- 📊 Analysis and reporting
- 📋 Compliance tracking
- 🔐 Security infrastructure
The platform automatically:
- 🧩 Matches similar patients
- 🏆 Identifies optimal treatments based on real-world outcomes
- 🚨 Spots potential problems early
- 📊 Shows comparative effectiveness
- 💲 Compares treatment costs
- 🔍 Helps patients find optimal care
Anyone can:
- 📚 Access aggregated and anonymized trial data
- 🛠️ Build new analysis tools to integrate with the platform
- 📱 Create patient apps
- 🛠️ Improve the platform
- ➕ Add new features
The platform supports:
- 🌐 Recognition of international safety data
- 📝 Harmonized global reporting standards
- 🤝 Cross-border research collaboration
- 💲 Transparent pricing across regions
- 🌎 International treatment access
- 🏢 Government-imposed fees block innovation:
- 💊 $4M fee for new drug applications
- 📊 $2M fee for applications without clinical data
- 💉 $1.4M annual program fee per approved drug
- 🚫 Impact on innovation:
- 🌱 Blocks small biotech startups
- 🔬 Prevents university research commercialization
- 🏥 Excludes non-profit organizations
- 👥 Stops patient-driven initiatives
- 🚫 Current import restrictions:
- ❌ Individual import largely illegal
- 🏥 No pharmacy imports for resale
- 🔄 Duplicate approval requirements
- ✅ Must repeat process even for proven treatments
- 🏭 Redundant facility inspections
- 📊 Duplicate clinical trials
- 📈 Price inflation factors:
- 💸 Duplicate regulatory costs passed to patients
- 🚫 Lack of international competition
- 🏢 Regional monopolies
- 📊 50-90% higher prices than other countries
- 💸 Eliminate government-imposed fees
- 🌍 Enable free importation from trusted sources:
- 🇪🇺 European Medicines Agency (EMA)
- 🇬🇧 UK's MHRA
- 🇯🇵 Japan's PMDA
- 🇨🇭 Swiss Medic
- 📊 Benefits:
- 💰 Lower treatment costs
- ⚡ Faster access to proven treatments
- 🏆 True price competition
- 🌐 Global price parity
- 🚫 Prevention of price gouging
- Average lifetime healthcare costs: $1.2M per person 📊
- ~80% of costs are from age-related diseases: $960k 👴
- Treatment reduces lifetime costs by: $750k per person 📉
- At $10k per treatment, 1 million people can afford it 👥
- Total lifetime savings: $750 billion 💰
- Society keeps: $375 billion in savings 🏥
- Manufacturer receives: $375 billion in rewards 🎯
- Additional savings from increased productivity and reduced care needs 📈
- Government healthcare costs cut in half 📉
- Patients save thousands on treatment costs 💰
- Insurance premiums drop dramatically ⬇️
- Taxpayers save trillions long-term 💎
- Healthcare becomes sustainably affordable 🌟
- Lower prices → More patients can afford treatment 💫
- More patients → Higher total savings generated 📈
- Higher savings → Bigger rewards for manufacturers 🎯
- Bigger rewards → More investment in cures 🚀
- More cures → Even more healthcare savings 💰
- Age reversal therapies 🧬
- Gene therapies 🧬
- Disease prevention treatments 🛡️
- Regenerative medicine 🔄
- Longevity treatments ⏳
- The Decentralized FDA tracks long-term health outcomes 📊
- Transparent savings calculations 🧮
- Independent verification of results ✅
- Automated payment distribution 💸
- 💸 Eliminates billions in redundant trial infrastructure costs
- 🚫 Removes expensive middlemen and administrative overhead
- 🌐 Enables global price competition through open access
- 💰 Shares cost savings from prevention back to developers
- 🏥 Reduces healthcare spending through earlier intervention
- 🛠️ Cuts development costs by over 90% through shared platform
- 🔄 Eliminates duplicate safety testing across regions
- ⏳ Removes years of administrative delays
- 🚀 Enables immediate trial participation for interested patients
- 🤖 Automates patient matching and enrollment
- 🕒 Provides real-time safety and efficacy monitoring
- 🧠 Accelerates treatment optimization through AI analysis
- Eliminates redundant approval processes across countries
- 🔄 Enables rapid iteration based on real-world evidence
- 👥 Includes all willing patients instead of just 3%
- 📊 Generates real-world evidence across diverse populations
- 🎯 Identifies optimal treatments for specific patient profiles
- 🚨 Catches safety issues earlier through comprehensive monitoring
- 🔄 Enables continuous improvement through global collaboration
- 🤝 Aligns profit incentives with actual health outcomes
- 🌍 Democratizes access to promising treatments